Concepedia

Complement activation in patients with COVID-19: A novel therapeutic target

Massimo Cugno, Pier Luigi Meroni, Roberta Gualtierotti, Samantha Griffini, Elena Grovetti, Adriana Torri, Mauro Panigada, Stefano Aliberti, Francesco Blasi, Francesco Tedesco,

Journal of Allergy and Clinical Immunology · 2020 · 256 citations · 6 references

DOIFull text

Open access

Concepts

References

6

Clinical Characteristics of Coronavirus Disease 2019 in China

Wei‐jie Guan, Zhengyi Ni, Yu Hu et al. · New England Journal of Medicine · 2020 · 31.2K citations · Full text

, , +10

Clinical and immunological features of severe and moderate coronavirus disease 2019

Guang Chen, Di Wu, Wei Guo et al. · Journal of Clinical Investigation · 2020 · 5.1K citations · Full text

, , +13

Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis

Lisa E. Gralinski, Timothy P. Sheahan, Thomas E. Morrison et al. · mBio · 2018 · 700 citations · Full text

, , +17

Human Kidney is a Target for Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

Bo Diao, Chenhui Wang, Rongshuai Wang et al. · medRxiv · 2020 · 489 citations · Full text

, , +16

High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.

Milan Bašta, Marinos C. Dalakas · Journal of Clinical Investigation · 1994 · 395 citations · Full text

, , +17